Active ingredient (in each tablet)

Sennosides 17.2 mg

Purpose

Laxative

Uses

relieves occasional constipation (irregularity)
generally causes bowel movement in 6-12 hours

Warnings

Do not use laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

stomach pain
nausea
vomiting
noticed a sudden change in bowel movements that continuesover a period of 2 weeks

Stop Use

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

Pregnancy or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use.

Keep Out of Reach of Children

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

Dosage Forms & Strengths

age	startingdosage	maximumdosage
adults and children 12 yearsof age and over	1 tablet once a day	2 tablets twice aday
children 6 to under 12 years	½ tablet once a day	1 tablet twice aday
children under 6	ask a doctor	ask a doctor

Other Information

each tablet contains: calcium 20mg
store at 25°C (75°F); excursions permitted between 15°-30°C (59°-86°F).

Inactive Ingredients

croscarmellose sodium, dicalcium phosphate, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, mineral oil, stearic acid, talc, tartaric acid

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Senokot® Extra Strength
36 Tablets Carton

Senokot® Extra Strength
12 Tablets Carton

Senokot® Extra Strength 36 Tablets Label

Senokot®
Standardized Senna Concentrate, 17.2mg

Extra
Strength

Natural vegetable
laxative Ingredient

72 Tablets

DO NOT USE IF SEAL UNDER CAP IS
MISSING OR DAMAGED.

A0725

LOT:

EXP:

R54038

Dist. by: Atlantis Consumer Healthcare Inc.
Bridgewater, NJ 08807 USA
Questions? 1-833-288-2684 www.senokot.com
©2025 Atlantis Consumer Healthcare Inc.

SENOKOT
standardized senna concentrate tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:67618-120
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	17.2 mg

Ingredient Name	Strength
Inactive Ingredients
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
TARTARIC ACID (UNII: W4888I119H)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
LIGHT MINERAL OIL (UNII: N6K5787QVP)
TALC (UNII: 7SEV7J4R1U)
STEARIC ACID (UNII: 4ELV7Z65AP)

Product Characteristics
Color	BROWN (Light Brown)	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	X
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:67618-120-12	1 in 1 CARTON	09/01/1988
1		12 in 1 BLISTER PACK; Type 0: Not a Combination Product
2	NDC:67618-120-36	3 in 1 CELLO PACK	09/01/1988	01/01/2023
2		12 in 1 BLISTER PACK
2		12 in 1 BLISTER PACK; Type 0: Not a Combination Product
3	NDC:67618-120-06	36 in 1 BOTTLE; Type 0: Not a Combination Product	09/01/1988
4	NDC:67618-120-72	2 in 1 PACKAGE	01/01/2024
4		1 in 1 CARTON
4		36 in 1 BOTTLE; Type 0: Not a Combination Product
5	NDC:67618-120-73	72 in 1 BOTTLE; Type 0: Not a Combination Product	11/15/2025

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M007	09/01/1988

Labeler - Atlantis Consumer Healthcare, Inc. (118983925)

Registrant - Atlantis Consumer Healthcare, Inc. (118983925)

SenokotXTRA (standardizedsenna concentrate) Drug Facts